Venous and arterial thrombosis in COVID-19: An updated narrative review

Venous and arterial thrombosis in COVID-19: An updated narrative review

Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted to the intensive care unit (ICU) are at high risk of morbidity and mortality. Several observational studies have described hemostatic derangements and thrombotic complications in patients with COVID-19. The a...

Descripció completa

Dades bibliogràfiques
Autors principals:	Zainab Al Duhailib, Simon Oczkowski, Kamil Polok, Jakub Fronczek, Wojciech Szczeklik, Joshua Piticaru, Manoj J. Mammen, Fayez Alshamsi, John Eikelboom, Emilie Belley-Cote, Waleed Alhazzani
Format:	Article
Idioma:	English
Publicat:	Elsevier 2022-06-01
Col·lecció:	Journal of Infection and Public Health
Matèries:	Anticoagulation COVID-19 Thrombosis Venous thromboembolism prophylaxis Critically ill D-dimer level
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S187603412200123X

Ítems similars

Risk Factors and Clinical Significance of D-Dimer in the Development of Postoperative Venous Thrombosis in Patients with Lung Tumor
per: Wang P, et al.
Publicat: (2020-06-01)

Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study
per: Sara Reda, et al.
Publicat: (2022-03-01)

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results
per: Gualtiero Palareti, et al.
Publicat: (2022-03-01)

Optimal duration of anticoagulant therapy in patients with venous thromboembolism
per: Gualtiero Palareti
Publicat: (2018-09-01)

A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years
per: Dylan A. Mistry, et al.
Publicat: (2017-10-01)

Thromboembolism in Arthroplasty: Compliance to Prophylaxis
per: Leandra Marla Aires Travassos Viana, et al.
Publicat: (2021-12-01)

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
per: U Vasudeva Rao, et al.
Publicat: (2021-01-01)

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database
per: Miguel Pisani, et al.
Publicat: (2022-10-01)

Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement
per: Alpesh N. Amin, et al.
Publicat: (2011-09-01)

Renal Vein Thrombosis in Idiopathic Thrombocytopenic Purpura
per: Subodh Kumar Das, et al.
Publicat: (2020-03-01)

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
per: Ciuculete Denisa-Corina, et al.
Publicat: (2021-09-01)

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider
per: Daria Solari, et al.
Publicat: (2021-01-01)

Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery
per: Taishi Hata, et al.
Publicat: (2019-09-01)

New knowledge of prophylaxis and treatment about cancer-associated thrombosis
per: DING Yongjie, ZHANG Liu, LI Qingyun
Publicat: (2023-08-01)

Cancer and Thrombosis: New Treatments, New Challenges
per: Anders Erik Astrup Dahm
Publicat: (2021-06-01)

Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease
per: Brittany Scarpato, et al.
Publicat: (2022-03-01)

The importance of D-dimer test in the follow up of patients with deep venous thrombosis
per: Meral Ekim, et al.
Publicat: (2018-07-01)

CONTINUOUS THROMBOPROPHYLAXIS DURING SURGICAL TREATMENT OF PATIENT WITH POLYTRAUMA IN A MULTIDISCIPLINARY HOSPITAL (CASE REPORT)
per: I. G. Belenky, et al.
Publicat: (2017-07-01)

Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
per: Chelsea Matzko, et al.
Publicat: (2021-12-01)

PULMONARY EMBOLISM IN BREAST CANCER: ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT APPROACHES
per: I. D. Rozanov, et al.
Publicat: (2017-01-01)

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series
per: Nicholas L.J. Chornenki, et al.
Publicat: (2024-08-01)

Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey
per: Hope P. Wilson, et al.
Publicat: (2022-03-01)

Consensus document on anticoagulant management of deep vein thrombosis: A review
per: V S Bedi, et al.
Publicat: (2021-01-01)

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
per: Peter W. Ketch, et al.
Publicat: (2024-12-01)

ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST
per: Samir Arnaout, et al.
Publicat: (2011-05-01)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
per: Hyeon-Jeong Lee, et al.
Publicat: (2023-05-01)

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
per: Marcello Di Nisio, et al.
Publicat: (2024-05-01)

Deep vein thrombosis - the review
per: Karol Stępniak, et al.
Publicat: (2024-11-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
per: Sidrah Shah, et al.
Publicat: (2021-05-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
per: Sven R. Olson, et al.
Publicat: (2019-07-01)

New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
per: Mehrie H. Patel, et al.
Publicat: (2024-05-01)

Cerebral vein thrombosis as the initial presentation of acute promyelocytic leukemia (APML)
per: Fizza Zulfiqar, et al.
Publicat: (2025-01-01)

Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
per: Fleur H.J. Kaptein, et al.
Publicat: (2024-01-01)

Preoperative prevalence of deep vein thrombosis in patients scheduled to have surgery for degenerative musculoskeletal disorders
per: Keigo Sato, et al.
Publicat: (2021-06-01)

Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
per: Philip L. Mar, MD, PharmD, et al.
Publicat: (2020-03-01)

Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy
per: Roberts JC, et al.
Publicat: (2022-10-01)

Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
per: W. Anthony Hawkins, et al.
Publicat: (2021-10-01)

D-dimer: a useful tool in gauging optimal duration of oral anticoagulant therapy?
per: M. Silingardi, et al.
Publicat: (2013-05-01)

An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study
per: Fumihiro Ogawa, et al.
Publicat: (2021-04-01)

Prevalence, Risk Factors of Deep Venous Thrombosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-sectional Study
per: P SPURTHY, et al.
Publicat: (2024-01-01)